Airway remodeling is absent in CCR1(-/-) mice during chronic fungal allergic airway disease

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1564-1572

  Blease, Kate ^a   Mehrad, Borna ^a   Standiford, Theodore J ^a   Lukacs, Nicholas W ^a   Kunkel, Steven L ^a   Chensue, Stephen W ^a,b   Lu, Bao ^c   Gerard, Craig J ^c   Hogaboam, Cory M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; ASTHMA; CYTOKINE RELEASE; HISTOPATHOLOGY; LUNG LAVAGE; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0034254180     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1564     Document Type: Article

References (47)

1. Douwes, J., B. van der Sluis, G. Doekes, F. van Leusden, L. Wijnands, R. van Strien. A. Verhoeff, and B. Brunekreef. 1999. Fungal extracellular polysaccharides in house dust as a market for exposure to fungi: relations with culturable fungi, reported home dampness, and respiratory symptoms. J. Allergy Clin. Immunol. 103:494.
2. Malo, J. L., and R. Paquin. 1979. Incidence of immediate sensitivity to Aspergillus fumigatus in a North American asthmatic population. Clin. Allergy 9:377
3. Holt, P. G., C. Maccaubas, P. A. Stumbles, and P. D. Sly. 1999. The role of allergy in the development of asthma. Nature 402:812.
4. Katz, Y., H. Verleger, J. Barr, M. Rachmiel, S. Kiviti, and E. S. Kultin. 1999. Indoor survey of moulds and prevalence of mould atopy in Israel. Clin. Exp. Allergy 29:186.
5. Cockrill, B. A., and C. A. Hales. 1999. Allergic bronchopulmonary aspergillosis. Annu. Rev. Med. 50:303.
6. Corry, D. B., G. Grunig, H. Hadeiba, V. P. Kurup, M. L. Warnock, D. Sheppard, D. M. Rennick, and R. M. Locksley. 1998. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol. Med. 4:344.
7. Barnes, P. J. 1996. Pathophysiology of asthma. Br. J. Clin. Pharmacol. 42:3.
8. Jeffery, P. K. 1991. Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir Dis. 143:1152.
9. Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1:520.
10. Holgate, S. T. 1997. Asthma: a dynamic disease of inflammation and repair. Ciba Found. Symp. 206:5.
11. Lukacs, N. W., S. H. Oliveira, and C. M. Hogahoam. 1999. Chemokines and asthma: redundancy of function or a coordinated effort? J. Clin. Invest. 104:995.
12. Holgate, S. T., K. S. Bodey, A. Janezic, A. J. Frew, A. P. Kaplan, and L. M. Teran. 1997. Release of RANTES, MIP-1α, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am. J. Respir. Crit. Care Med. 156:1377.
13. Alam, R., J. York, M. Boyars, S. Stafford, J. A. Grant, J. Lee, P. Forsythe, T. Sim, and N. Ida. 1996. Increased MCP-1. RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 153: 1398.
14. Lukacs, N. W., T. J. Standiford, S. W. Chensue, R. G. Kunkel, R. M. Strieter, and S. L. Kunkel. 1996. C-C chemokine-induced eosinophil chemotaxis during allergic airway inflammation. J. Leukocyte Biol. 60:573.
15. Gonzalo, J. A., C. M. Lloyd, D. Wen, J. P. Albar, T. N. Wells, A. Proudfoot, A. C. Martinez, M. Dorf, T. Bjerke, A. J. Coyle, et al. 1998. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. 188:157.
16. Campbell, E. M., S. L. Kunkel, R. M. Strieter, and N. W. Lukacs. 1998. Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. J. Immunol. 161:7047.
17. Proudfoot, A. E., T. N. Wells, and P. R. Clapham. 1999. Chemokine receptors: future therapeutic targets for HIV? Biochem. Pharmacol 57:451.
18. Wells, T. N., C. A. Power, M, Lusti-Narasimhan, A. J. Hoogewerf, R. M. Cooke, C. W. Chung, M. C. Peitsch, and A. E. Proudfoot. 1996. Selectivity and antagonism of chemokine receptors. J. Leukocyte Biol. 59:53.
19. Smith, R. E., R. M. Strieter, K. Zhang, S. H. Phan, T. J. Standiford, N. W. Lukacs, and S. L. Kunkel. 1995. A role for C-C chemokines in fibrotic lung disease. J. Leukocyte Biol. 57:782.
20. Smith, R. E. 1996. Chemotactic cytokines mediate leukocyte recruitment in fibrotic lung disease. Biol. Signals 5:223.
21. Gerard, C., J. L. Frossard, M. Bhatia, A. Saluja, N. P. Gerard, B. Lu, and M. Steer. 1997. Targeted disruption of the α-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J. Clin. Invest. 100:2022.
22. Hogaboam, C. M., K. Blease, B. Mehrad, M. L. Steinhauser, T. J. Standiford, S. L. Kunkel, and N. W. Lukacs. 2000. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am. J. Pathol. 156:723.
23. Hogaboam, C. M., C. S. Gallinat, D. D. Taub, R. M. Strieter, S. L. Kunkel, and N. W. Lukacs. 1999. Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis. J. Immunol. 162:6071.
24. Lukacs, N. W., C. Addison, J. Gauldie, F. Graham, K. Simpson, R. M. Strieter, K. Warmington, S. W. Chensue, and S. L. Kunkel. 1997. Transgene-induced production of IL-4 alters the development and collagen expression of T helper cell 1-type pulmonary granulomas. J. Immunol. 158:4478.
25. Evanoff, H., M. D. Burdick, S. A. Moore, S. L. Kunkel, and R. M. Strieter. 1992. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol. Invest. 21:39.
26. Keane, M. P., J. A. Belperio, T. A. Moore, B. B. Moore, D. A. Arenberg, R. E. Smith, M. D. Burdick, S. L. Kunkel, and R. M. Strieter. 1999. Neutralization of the CXC chemokine, macrophage Inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 162:5511.
27. Gao, J. L., T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon-Chung, and P. M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2-cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1959.
28. Topham, P. S., V. Csizmadia, D. Soler, D. Hines, C. J. Gerard, D. J. Salant, and W. W. Hancock. 1999. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J. Clin. Invest. 104: 1549.
29. Gonzalo, J. A., Y. Pan, C. M. Lloyd, G. Q. Jia, G. Yu, B. Dussault, C. A. Powers, A. E. Proudfoot, A. J. Coyle, D. Gearing, and J. C. Gutierrez-Ramos. 1999. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J. Immunol. 163:403.
30. Schaffner, A., H. Douglas, and A. Braude. 1982. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 69:617.
31. Taramelli, D., M. G. Malabarba, G. Sala, N. Basilico, and G. Cocuzza. 1996. Production of cytokines by alveolar and peritoneal macrophages stimulated by Aspergillus fumigatus conidia or hyphae. J. Med. Vet. Mycol. 34:49.
32. Mehrad, B., R. M. Strieter, and T. J. Standiford. 1999. Role of TNF-α in pulmonary host defense in murine invasive aspergillosis. J. Immunol. 162:1633.
33. Drazen, J. M., T. Takebayashi, N. C. Long, G. T. De Sanctis, and S. A. Shore. 1999. Animal models of asthma and chronic bronchitis. Clin. Exp. Allergy 2(Suppl. 2):37.
34. Stafford, S., H. Li, P. A. Forsythe, M. Ryan, R. Bravo, and R. Alam. 1997. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (F1C) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J. Immunol. 158:4953.
35. Reed, C. E. 1999. The natural history of asthma in adults: the problem of irreversibility. J. Allergy Clin. Immunol. 103:539.
36. Boulet, L. P., J. Chakir, J. Dube, C. Laprise, M. Boutet, and M. Laviolette. 1998. Airway inflammation and structural changes in airway hyper-responsiveness and asthma: an overview. Can. Respir. J. 5:16.
37. Hoshino, M., Y. Nakamura, J. Sim, J. Shimojo, and S. Isogai. 1998. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J. Allergy Clin. Immunol. 102:783.
38. Krishnaswamy, G., J. Kelley, J. K. Smith, and D. S. Chi. 1999. Therapeutic implications of airway remodeling in asthma. Veterans Health System Journal 4:44.
39. Chu, H. W., J. L. Halliday, R. J. Martin, D. Y. Leung, S. J. Szefler, and S. E. Wenzel. 1998. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am. J. Respir. Crit. Care Med. 158:1936.
40. Li, L., Y. Xia, A. Nguyen, L. Feng, and D. Lo. 1998. Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J. Immunol. 161:3128.
41. Hofstra, C. L., I. Van Ark, G. Hofman, M. Kool, F. P. Nijkamp, and A. J. Van Oosterhout. 1998. Prevention of Th2-like cell responses by co-administration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J. Immunol. 161: 5054.
42. Cohn, L., R. J. Homer, N. Niu, and K. Bottomly. 1999. T helper 1 cells and Interferon γ regulate allergic airway inflammation and mucus production. J. Exp. Med. 190:1309.
43. Jeffery, P. K. 1992. Histological features of the airways in asthma and COPD. Respiration 5(Suppl 1):13.
44. Garlisi, C. G., A. Falcone, J. A. Hey, T. M. Paster, X. Fernandez, C. A. Rizzo, M. Minnicozzi, H. Jones, M. M. Billah, R. W. Egan, et al. 1997. Airway eosinophils, T cells, Th2-type cytokine mRNA, and hyperreactivity in response to aerosol challenge of allergic mice with previously established pulmonary inflammation. Am. J. Respir. Cell Mol. Biol. 17:642.
45. Doucet, C., D. Brouty-Boye, C. Pottin-Clemenceau, C. Jasmin, G. W. Canonica, and B. Azzarone. 1998. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int. Immunol. 10:1421.
46. Doucet, C., D. Brouty-Boye, C. Pottin-Clemenceau, G. W. Canonica, C. Jasmin, and B. Azzarone. 1998. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts: implication in asthma. J. Clin. Invest. 101:2129.
47. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779.